High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.
about
Role of PD-1 in HIV pathogenesis and as target for therapyHIV-1 functional cure: will the dream come true?Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutionsRe-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infectionMechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infectionLow Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort StudyCycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation.Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot studyGalectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.Attenuation of immune activation in an open-label clinical trial for HIV-AIDS using a polyherbal formulation.Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease.T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.Cytokine network in adults with falciparum Malaria and HIV-1: increased IL-8 and IP-10 levels are associated with disease severity.Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohortImmune response to Leishmania antigens in an AIDS patient with mucocutaneous leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome (IRIS): a case reportAtorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral ReservoirLow antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohortVirologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T CellsCD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda.High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected womenDynamics of cytokine/chemokine responses in intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus InfectionPoor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans.Low Double-Negative CD3+CD4-CD8- T Cells Are Associated with Incomplete Restoration of CD4+ T Cells and Higher Immune Activation in HIV-1 Immunological Non-RespondersVirological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children.High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.Immunodiscordant responses to HAART--mechanisms and consequences.Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery.The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART.Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya.Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety.Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recoveryHIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution.
P2860
Q24634293-698ACC10-0313-4348-884A-6C715CF95292Q26865803-BA67F644-485F-4553-A47A-1083BDBE4B4EQ27021524-65D34FFA-11FE-4467-BD25-5D2D2FB0955AQ27331338-672FB91E-A558-4C66-9883-1533D6EAEC72Q28081838-D6E0155B-E0FF-443A-9CE8-85ADB9F82E35Q28550552-D75C2051-FE40-4741-9A0E-5BD5985A862FQ33602906-E3CAA635-C792-433C-A028-5F3D62E4E3F6Q33632786-5A6E4AA2-2DD3-43B2-92C7-E542B7F65F72Q33828349-CEE4ED8D-B1BF-4730-B1F5-91B9A8B217C3Q33933071-EAE39999-D404-4280-8767-94A4FA0F711BQ34059178-B35FD992-56A8-46F4-B2D6-993662A7A9C9Q34300102-26FC3300-0A61-4C5E-A709-4A902F27DA21Q34373981-A3B772C9-626C-4BCE-A5B2-98DAA0C2A436Q34388154-FB4FAAE1-E854-4943-BB31-3414AD7C2134Q34411977-D68FC8AB-4CAB-4F04-997F-01B4B7300558Q34682109-E7890EF3-3EA2-49DF-90DA-4215CB8EA735Q34779237-9F089027-BCE7-4573-BBFB-906876C40EF9Q35553902-51ADBCA4-FC01-4E01-8DBF-444FB251C820Q35929446-35A5263B-8E9B-4BC0-BE37-AEF58B177AA1Q35946786-18AF71C0-C172-4641-A175-B6EEA3CDEB37Q35956923-6CBEE902-80EE-445D-9036-149EC74FE793Q36263361-EAA3AD8D-BCE9-492E-B99F-2F0957A329FDQ36360872-C3694407-03F7-466B-B36F-F538E9D1A1EAQ36974205-A01C964F-F328-4186-8978-41F7528D45B4Q37002936-483A7938-6015-4BC6-BD27-D252ED9B8E51Q37012660-B92D6AF7-977D-43AC-88CA-53A50F7138C4Q37252772-545E020C-16DE-436A-B65D-74E80BFCB07CQ37378374-3E10226A-F572-403F-B639-80AB9F56D9ACQ37486642-A1B62D36-B288-4156-9938-427164C48C07Q37509894-F055515A-A2D1-429E-9A54-42B45D5B4CA4Q37558647-85A55618-F7A8-4994-89B7-B1B638582EFBQ38156230-52621401-78F3-476C-B76D-E0419BCE4CADQ38826536-F37F37E6-3C97-4B41-A0D6-2BE3D06C9E44Q38866845-4CB7FCE9-AD27-41EF-A4D8-396982FDDBE9Q38869327-7C8837CA-FAB6-4752-B68E-67C64C0A66B8Q39422439-D4A60349-A9A1-4FBD-91CB-84B2AE730D57Q41295794-27CCA555-01EB-4C3F-9CA4-ED1CADBEEAE3Q41333604-298EC821-01D4-44F6-ADD8-8059C69D5C01Q41718407-BAA1BA11-5799-4D46-A85D-32707E072367Q41920878-FC6276EB-C51B-4B57-B214-A5D05B698D6A
P2860
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High T-cell immune activation ...... therapy in an African cohort.
@ast
High T-cell immune activation ...... therapy in an African cohort.
@en
type
label
High T-cell immune activation ...... therapy in an African cohort.
@ast
High T-cell immune activation ...... therapy in an African cohort.
@en
prefLabel
High T-cell immune activation ...... therapy in an African cohort.
@ast
High T-cell immune activation ...... therapy in an African cohort.
@en
P2093
P2860
P50
P356
P1476
High T-cell immune activation ...... therapy in an African cohort.
@en
P2093
Isaac Ssewanyana
Rose Nabatanzi
Yukari C Manabe
P2860
P2888
P356
10.1186/1471-2334-11-43
P577
2011-02-08T00:00:00Z